This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Corvus Pharmaceuticals, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Jingrong Xu in Pharmaceutical Formulations
Introduction
Jingrong Xu is an accomplished inventor based in Burlingame, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy of cancer treatments through advanced pharmaceutical compositions.
Latest Patents
Jingrong Xu holds a patent for pharmaceutical formulations that include micronized drug particles of adenosine A2A receptor antagonists. This patent outlines methods for treating cancer using these specialized pharmaceutical compositions. His innovative approach aims to improve the delivery and effectiveness of cancer therapies.
Career Highlights
Jingrong Xu is currently employed at Corvus Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical sciences. His expertise in drug formulation has positioned him as a valuable asset in the fight against cancer.
Collaborations
Jingrong has collaborated with notable colleagues such as William Benton Jones and Felicia Flicker. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Jingrong Xu's contributions to pharmaceutical formulations demonstrate his commitment to improving cancer treatment options. His innovative work continues to pave the way for advancements in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile